IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Clinical trial NCT00349934 · COMPLETED
Trial details
- NCT number
- NCT00349934
- Sponsor
- Immutep S.A.S.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.